Potential role of nutraceutical compounds in inflammatory bowel disease

Conventional therapies for inflammatory bowel diseases (IBD) involve combinations of pharmacologic agents such as aminosalicylates, azathioprine, and corticosteroids. Recently, the therapeutic scenario has been heavily increased by the introduction of agents including monoclonal antibodies targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Larussa, Tiziana, Imeneo, Maria, Luzza, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394511/
https://www.ncbi.nlm.nih.gov/pubmed/28465632
http://dx.doi.org/10.3748/wjg.v23.i14.2483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394511/
https://www.ncbi.nlm.nih.gov/pubmed/28465632
http://dx.doi.org/10.3748/wjg.v23.i14.2483

Ejemplares similares